OTCMKTS:EAPHEaston Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Easton Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0009 0.00 (0.00 %) (As of 07/7/2020 04:00 PM ET) Add Compare Share Today's Range$0.00Now: $0.00▼$0.0050-Day Range N/A52-Week Range$0.00Now: $0.00▼$0.00Volume785,500 shsAverage Volume722,500 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlinesSocial Media Easton Pharmaceuticals Inc., a specialty pharmaceutical company, designs, develops, and markets various topically delivered drugs and therapeutic health care products. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug. The company is also developing XILIVE, an early stage cancer drug. In addition, it is involved in the medical marijuana business. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is based in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Easton Pharmaceuticals. Previous Next 2.4 Community Rank Outperform VotesEaston Pharmaceuticals has received 82 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEaston Pharmaceuticals has received 91 “underperform” votes. (Add your “underperform” vote.)Community SentimentEaston Pharmaceuticals has received 52.60% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Easton Pharmaceuticals and other stocks. Vote “Outperform” if you believe EAPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EAPH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEaston Pharmaceuticals does not currently pay a dividend.Dividend GrowthEaston Pharmaceuticals does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Easton Pharmaceuticals insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:EAPH Previous Symbol CUSIPN/A CIKN/A Webwww.eastonpharmaceuticalsinc.com Phone416-619-0291Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:EAPH Rates by TradingView Receive EAPH News and Ratings via Email Sign-up to receive the latest news and ratings for EAPH and its competitors with MarketBeat's FREE daily newsletter. Easton Pharmaceuticals (OTCMKTS:EAPH) Frequently Asked Questions How has Easton Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)? Easton Pharmaceuticals' stock was trading at $0.0008 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, EAPH stock has increased by 12.5% and is now trading at $0.0009. View which stocks have been most impacted by Coronavirus. Has Easton Pharmaceuticals been receiving favorable news coverage? News articles about EAPH stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Easton Pharmaceuticals earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Easton Pharmaceuticals. Who are some of Easton Pharmaceuticals' key competitors? Some companies that are related to Easton Pharmaceuticals include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF) and CLS Holdings USA (CLSH). View all competitors. What other stocks do shareholders of Easton Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Easton Pharmaceuticals investors own include 22nd Century Group (XXII), Medmen Enterprises (MMNFF), CannaRoyalty (ORHOF), Canopy Growth (CGC), Emerald Health Therapeutics (EMHTF), GreenGro Technologies (GRNH), mCig (MCIG), Aurora Cannabis (ACBFF), GB Sciences (GBLX) and KushCo (KSHB). Who are Easton Pharmaceuticals' key executives? Easton Pharmaceuticals' management team includes the following people: Mr. Evan Karras, CEO, Pres, Sec. & DirectorMr. Nunzio J. Valerie Jr., CFO & Director (Age 57)Mr. Vince Demasi, COO & DirectorDr. Lilla Albert Ph.D., Chief Marketing and Technology OfficerMs. Elena Milantoni, Director of Fin. and Admin. (Age 49) What is Easton Pharmaceuticals' stock symbol? Easton Pharmaceuticals trades on the OTCMKTS under the ticker symbol "EAPH." How do I buy shares of Easton Pharmaceuticals? Shares of EAPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Easton Pharmaceuticals' stock price today? One share of EAPH stock can currently be purchased for approximately $0.00. What is Easton Pharmaceuticals' official website? The official website for Easton Pharmaceuticals is www.eastonpharmaceuticalsinc.com. How can I contact Easton Pharmaceuticals? The company can be reached via phone at 416-619-0291. This page was last updated on 7/7/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
